International Journal of Nanomedicine · 2020 · 63 citations · 31 references
PharmacyBiochemistryPharmacologyBioavailabilityDrug DeliveryNanoparticle Drug DeliveryDiabetic NephropathyLipid-based NanoparticlesNanomaterials For Drug DeliveryNanomedicineNanoparticle-based BioavailabilityRenal PharmacologyAnti-inflammatory ActivityAnti-inflammatory MechanismsLipid NanoparticlesLipid Peroxidation MarkersNanoparticle PharmacologyNrf2 Signaling PathwayOxidative Stress InjuryRenal Tissue Injury
BACKGROUND: Apigenin is known to have a broad-spectrum efficacy in oxidative stress and conditions due to inflammation, although weak absorption, fast metabolic rate and a fast elimination (systemic) limit the pharmacological efficacy of this drug. Hence, we propose the usage of highly bioavailable Apigenin-solid lipid nanoparticles (SLNPs) to recognize such limitations. The defensive function of Apigenin-SLNPs on renal damage induced by streptozotocin (STZ) in animals was studied. MATERIALS AND METHODS: ) for a continuous period of 30 days. We then measured the level of insulin and blood glucose, superoxide dismutase, catalase and malondialdehyde in the tissues of the kidney. We also observed messenger-RNA expression of Interleukin-1β, Interleukin-6 and Tumor Necrosis Factor-alpha in renal tissue through RT-PCR technique. Moreover, H&E staining and Western blotting observed the histopathological variations and protein expression of nuclear factor erythroid 2-related factor 2/heme oxygenase/Nuclear Factor-κB signaling pathway, respectively. RESULTS: An enhancement in the expressing of nuclear factor erythroid 2-related factor 2 and heme oxygenase-1 and a suppression in the expression of Nuclear Factor-κB occurred due to Apigenin-SLNPs treatment, which was a result of the protective mechanism of Apigenin-SLNPs which is because of not only its anti-inflammatory function (by inhibition of release of inflammatory factors) but also their anti-oxidant activity (through reduction of lipid peroxidation production). CONCLUSION: We found that a protective effect on diabetic nephropathy was shown due to Apigenin-SLNPs, in rats induced with streptozocin maybe through the pathway of nuclear factor erythroid 2-related factor 2/heme oxygenase-1/Nuclear Factor-κB.
31
S. Subramanian · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2011 · 381 citations · Full text
Medicine, Biochemistry, Nephrology +17
Ritu Khanra, Saikat Dewanjee, Tarun Kumar Dua et al. · Journal of Translational Medicine · 2015 · 137 citations · Full text
Life Sciences, Botany, Pharmacology +17
Nelli Giribabu, Kamarulzaman Karim, Eswar Kumar Kilari et al. · Journal of Ethnopharmacology · 2017 · 93 citations